Prox1 transcription factor as a marker for vascular tumors - Evaluation of 314 vascular endothelial and 1086 nonvascular tumors

American Journal of Surgical Pathology

Volumn 36, Issue 3, 2012, Pages 351-359

  Miettinen, Markku ^a   Wang, Zeng Feng ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

angiosarcoma; CD34; hemangioendothelioma; hemangioma; lymphangioma; podoplanin; Prox1

Indexed keywords

CD34 ANTIGEN; HOMEODOMAIN PROTEIN; PROSPERO RELATED HOMEOBOX 1 PROTEIN; PROSPERO-RELATED HOMEOBOX 1 PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ANGIOSARCOMA; ARTICLE; CHEMISTRY; EPITHELIUM CELL; HEMANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL ENDOTHELIUM; PATHOLOGY; PREDICTIVE VALUE; VASCULAR TUMOR;

ANTIGENS, CD34; ENDOTHELIUM, LYMPHATIC; EPITHELIAL CELLS; HEMANGIOMA; HEMANGIOSARCOMA; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, VASCULAR TISSUE; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84857654556     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318236c312     Document Type: Article

References (31)

1. Arai E, Kuramochi A, Tsuchida T, et al. Usefulness of D2-40 immunohisto-chemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma. J Cutan Pathol. 2006;33:492-497.
2. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385-394.
3. Burke Z, Oliver G. Prox1 is an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. Mech Dev. 2002;118:147-155.
4. Dadras SS, Skrzypek A, Nguyen L, et al. Prox-1 promotes invasion of kaposiform hemangioendotheliomas. J Invest Dermatol. 2008;128:2798-2806.
5. Dudas J, Papoutsi M, Hecht M, et al. The homeobox transcription factor Prox1 is highly conserved in embryonic hepatoblasts and in adult and transformed hepatocytes, but is absent from bile duct epithelium. Anat Embryol (Berl). 2004;208:359-366.
6. Dudas J, Elmaouhoub A, Masuroglu T, et al. Prospero-related homeobox 1 (Prox1) is a stable hepatocyte marker during liver development, injury and regeneration, and is absent from "oval cells". Histochem Cell Biol. 2006;126:549-562.
7. Fanburg-Smith JF, Michal M, Partanen TA, et al. Papillary intralymphatic angio-endothelioma (PILA): a report of 12 cases of a distinctive vascular tumor with phenotypic features of lymphatic vessels. Am J Surg Pathol. 1999;23:1004-1010.
8. Harvey NL, Srinivasan RS, Dillard ME, et al. Lymphatic vascular defects promoted by Prox1 haploinsufficiency caused adult-onset obesity. Nat Genet. 2005;37:1072-1081.
9. Hirakawa S, Hong YK, Harvey N, et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol. 2003;162:575-586.
10. Hong YK, Detmar M. Prox1, master regulator of the lymphatic vasculature phenotype. Cell Tissue Res. 2003;314:85-92.
11. Hong YK, Foreman K, Shin JW, et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet. 2004;36:683-685.
12. Johnson NC, Dillard ME, Baluk P, et al. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev. 2008;22:3282-3291.
13. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40 a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440.
14. Kalof AN, Cooper K. D2-40 immunohistochemistry-so far. Adv Anat Pathol. 2009;16:62-64.
15. Laerm A, Helmbold P, Goldberg M, et al. Prospero-related homeobox 1 (PROX1) is frequently inactivated by genetic deletions and epigenetic silencing in carcinomas of the biliary system. J Hepatol. 2007;46:89-97.
16. Le Huu AR, Jokinen CH, Rubin BP, et al. Expression of Prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol. 2010;34:1563-1573.
17. Marler JJ, Mulliken JB. Vascular anomalies-classification, diagnosis, and natural history. Review. Facial Plast Surg Clin North Am. 2001;9:495-504.
18. Mentzel T, Kuzner H. Tumors of the lymphatic vessels of the skin and soft tissue. Pathologe. 2002;23:118-127.
19. Miettinen M, Miettinen M, Wang ZF, et al. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol. 2011;35:432-441.
20. Miettinen M, Sarlomo-Rikala M, Wang ZF. Claudin 5 as immunohisto-chemical marker for angiosarcoma and hemangioendotheliomas. Am J Surg Pathol. 2011. [Epub ahead of print].
21. Mishima K, Watabe T, Saito A, et al. Prox1 induces lymphatic endothelial differentiation via integrin alpha-9 and other signaling cascades. Mol Biol Cell. 2007;18:1421-1429.
22. Nguyen VA, Kutzner H, Furhapter C, et al. Infantile hemangioma is a proliferation of LYVE-1 negative blood endothelial cells without lymphatic competence. Mod Pathol. 2006;19:291-298.
23. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor 3 in 185 vascular tumors. Cancer. 1999;86:2406-2412.
24. Perkins P, Weiss SW. Spindle cell hemangioendothelioma: an analysis of 78 cases with reassessment of its pathogenesis and biologic behavior. Am J Surg Pathol. 1996;20:1196-1204.
25. Petrova TV, Nykanen A, Norrmen C, et al. Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell. 2008;13:407-419.
26. Riseboro CA, Searles RG, Melville AA, et al. Prox1 maintains muscle structure and growth in the developing heart. Development. 2009;136:495-505.
27. Traweek ST, Kandalaft PL, Mehta P, et al. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol. 1991;96:25-31.
28. Versmold G, Felsberg J, Mikeska T, et al. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer. Int J Cancer. 2007;121:547-554.
29. Weninger W, Partanen TA, Breiteneder-Geleff S, et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest. 1999;79:243-251.
30. Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002;7:1505-1513.
31. Wilting J, Papoutsi M, Christ B, et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J. 2002;16:1271-1273.